A NEW study suggests that the pattern of recurrence, rather than recurrence itself, is the key determinant of long-term outcomes following curative resection for hepatocellular carcinoma (HCC). HCC ...

A new risk score can help predict which pancreatic cancer survivors are more likely to suffer a recurrence of their cancer, researchers said. The score could help better manage the follow-up care for ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy ...

There is a need for individualized postoperative management and improved risk stratification among individuals with CD undergoing ileocolic resection. Postoperative recurrence after ileocolic ...

According to the American Cancer Society, there are more than 4 million breast cancer survivors in the United States, including women still undergoing treatment and those who have finished treatment.

Background: The overall incidence of liver metastasis in colorectal cancer is as high as 50%, and surgery remains the only potentially curative approach for the metastatic disease. The recurrence rate ...

Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...

Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves heart health. Aggressive lifestyle and risk factor modification (LRFM) was ...

Weekend mornings anchor, CBS New York; Correspondent, CBS News and Stations Elaine Quijano is a weekend mornings anchor for CBS New York and a correspondent for CBS News and Stations, contributing to ...

Official support for free-threaded Python, and free-threaded improvements Python’s free-threaded build promises true parallelism for threads in Python programs by removing the Global Interpreter Lock ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...